Developer docs
API playgroundTry for free, no card

Search company profiles

中山市创艺生化工程有限公司

Full company profile

uuid004h8yi

Namestring
中山市创艺生化工程有限公司
Legal namestring
中山市创艺生化工程有限公司
Websiteurl
gd-cy.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Zhongshan Chuangyi Biochemical Engineering Co., Ltd. (中山市创艺生化工程有限公司 / CYBIO) is a privately held Chinese in-vitro diagnostics (IVD) manufacturer founded in 1999 and headquartered in Zhongshan, Guangdong Province, with a satellite R&D center in Shenzhen established in 2014. The company designs, manufactures, and sells diagnostic instruments and the corresponding consumable reagents for clinical laboratories and point-of-care settings. Its instrument portfolio spans the CYB-series of five-part differential hematology analyzers (CYB-5200, CYB-5500, CYB-6000, CYB-6800), the CYFIA-series and AFS-4000 dry immunofluorescence POCT analyzers, and an integrated all-in-one platform combining bidirectional-LIS hematology analysis with fluorescence immunoassay. The reagent portfolio covers hematology reagents, biochemistry reagents, immune-assay system reagents, urine sediment detection reagents, and a COVID-19 2019-nCoV IgM/IgG fluorescence immunochromatographic test kit. The company's core technical differentiator is an industry-first ultrasonic anti-clog method that clears counting apertures in 3–15 minutes, reducing downtime versus conventional systems.

The business operates a hybrid go-to-market model: direct sales support for key hospital and clinical-lab accounts, complemented by a national distributor network of 300+ dealers reaching 1,000+ terminal customers across China, plus international export channels covering the Middle East, West Asia, Africa, Latin America, and Eastern Europe (including Romania and Poland). Revenue is generated through hardware sales of instruments paired with recurring reagent consumables, which is the standard IVD razor-and-blade model. The company holds ISO 9001, ISO 13485, EU CE, and US FDA certifications, and is designated a National High-tech Enterprise with a 2019 Guangdong R&D innovation rating of A3 (top 2% province-wide). Manufacturing is conducted at a 15 mu (≈2.5-acre) factory in Zhongshan's National Health Industry Base, with a workforce of approximately 200 employees including 70 R&D staff, an in-house doctor workstation, and a provincial/municipal engineering technology research center.

The company has pursued an IPO initiative since 2016 and has historically expanded through internal R&D and product launches rather than M&A. Leadership is concentrated in founder He Linhui (何林辉), who serves as General Manager and has driven the firm's 21-year IVD focus. The most recent strategic pivot was a 2020 product portfolio expansion to include a COVID-19 rapid serology kit and emergency disinfectant production in response to the pandemic, alongside formal performance-management reforms and a planned hematology reagent production line renovation.

Short descriptiontext

Zhongshan Chuangyi Biochemical Engineering Co., Ltd. (CYBIO) is a privately held Chinese IVD manufacturer producing five-part differential hematology analyzers, POCT fluorescence immunoassay instruments, and biochemical/immune/urine reagents for hospital clinical laboratories and point-of-care settings, distributed through 300+ China dealers and export channels across emerging markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersZhongshan, China
HQ citystring
Zhongshan
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
in-vitro diagnostics, hematology analyzers, clinical chemistry reagents, immunoassay reagents, point-of-care testing
Industry1 code
SECONDARYHLAHAAAB
Hematology & Coagulation Diagnostics
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
Product category
In-Vitro Diagnostics (IVD)
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1Hematology Analyzers and Reagents
TypeHardware Sales
Description

Sale of 5-part differential hematology analyzers (CYB series) and compatible blood cell analysis reagents. Instruments sold alongside consumable reagent packages, creating recurring revenue from reagent restocking.

gd-cy.com
2Biochemical Reagents
TypeHardware Sales
Description

Biochemical analyzer reagents for clinical chemistry testing, sold as consumable reagents.

gd-cy.com
3Immune Analyzer Reagents
TypeHardware Sales
Description

System reagents and fluorescence immunochromatography reagent kits for immune analyzers, including COVID-19 IgM/IgG detection kit.

gd-cy.com
4Urine Analysis Reagents
TypeHardware Sales
Description

Urinary sediment detection reagents for urine analysis testing.

gd-cy.com
5POCT Instruments and Reagents
TypeHardware Sales
Description

Point-of-care testing instruments (CYFIA series, AFS-4000) and associated dry fluorescence immunoassay reagent kits for rapid bedside diagnostics.

gd-cy.com
6Disinfectant Products
TypeHardware Sales
Description

During the COVID-19 pandemic, the company pivoted to produce disinfectant products (84消毒液, 复方季铵盐消毒剂, 聚维酮碘消毒剂) to support epidemic control, donated valued at 300,000 yuan.

gd-cy.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Zhongshan Chuangyi Biochemical Engineering Co., Ltd. (CYBIO) is an in-vitro diagnostics (IVD) manufacturer that designs, produces, and sells clinical laboratory instruments and reagents. The product portfolio includes five-part differential hematology analyzers (CYB-5200, CYB-5500, CYB-6000, CYB-6800), dry fluorescence immunofluorescence POCT analyzers (CYFIA-2000, CYFIA-3000, AFS-4000), an integrated bidirectional LIS hematology-immunoassay all-in-one platform, and a full reagent line covering hematology, biochemistry, immunoassay, urine analysis, and COVID-19 IgM/IgG detection.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • R&D innovation capability rated A3 (top 2% in Guangdong province, top 8 in Zhongshan city)
+2 more records
Product overview1 text field

Zhongshan Chuangyi Biochemical Engineering Co., Ltd (中山市创艺生化工程有限公司 / CYBIO) is a professional in-vitro diagnostics (IVD) manufacturer offering a dual-track product portfolio: (1) diagnostic instruments — the CYB-series five-part differential hematology analyzers (CYB-5200, CYB-5500, CYB-6000, CYB-6800) featuring proprietary ultrasonic anti-clog technology; the CYFIA-series and AFS-4000 dry immunofluorescence POCT analyzers; and the integrated All-in-One platform combining bidirectional LIS hematology and fluorescence immunoassay in a single system; (2) IVD reagents — covering biochemistry analyzer reagents, hematology analyzer reagents, immune analyzer system reagents, urine sediment detection reagents, and the COVID-19 2019-nCoV IgM/IgG fluorescence immunochromatographic test kit. The company operates two R&D centers (Zhongshan and Shenzhen) and maintains nationwide sales coverage in China plus international distribution in the Middle East, Africa, Latin America, and Europe.

Product and service13 records
1CYB-5200 Five-Diff Hematology Analyzer
CategoryIn-vitro diagnostic instrument (hematology analyzer)
Description

A five-part differential hematology analyzer for automated blood cell counting and classification in clinical laboratory settings.

2CYB-5500 Five-Diff Hematology Analyzer
CategoryIn-vitro diagnostic instrument (hematology analyzer)
Description

A five-part differential hematology analyzer representing the company's flagship hematology instrument line for clinical blood cell analysis.

3CYB-6000 Five-Diff Hematology Analyzer
CategoryIn-vitro diagnostic instrument (hematology analyzer)
Description

A five-part differential hematology analyzer in the CYB series, designed for automated hematology testing in clinical settings.

4CYB-6800 Five-Diff Hematology Analyzer
CategoryIn-vitro diagnostic instrument (hematology analyzer)
Description

A five-part differential hematology analyzer featuring proprietary ultrasonic anti-clog technology that clears counting apertures in 3-15 minutes, with bidirectional LIS connectivity.

5CYFIA-2000 Dry Immunofluorescence Analyzer
CategoryIn-vitro diagnostic instrument (POCT)
Description

A dry fluorescence immunofluorescence analyzer for point-of-care testing, designed for rapid bedside or clinic-side diagnostic results.

6CYFIA-3000 Dry Immunofluorescence Analyzer
CategoryIn-vitro diagnostic instrument (POCT)
Description

A dry fluorescence immunofluorescence analyzer for POCT use, supporting single-channel testing workflows in clinical and point-of-care environments.

7AFS-4000 Full-Automatic Dry Immunofluorescence Analyzer
CategoryIn-vitro diagnostic instrument (POCT)
Description

A fully automatic dry fluorescence immunofluorescence analyzer designed for high-throughput clinical diagnostic testing at point of care.

8Two-Way LIS Hematology Analyzer – Fluorescence Immunoanalyzer All-in-One Instrument
CategoryIn-vitro diagnostic instrument (integrated platform)
Description

An integrated analysis platform combining five-diff hematology analysis with fluorescence immunoassay capabilities, featuring bidirectional LIS connectivity for seamless laboratory data management.

9Reagents for Chemistry (Biochemical) Analyzer
CategoryIn-vitro diagnostic reagent (biochemistry)
Description

Biochemical assay reagents compatible with chemistry analyzers, forming part of the company's IVD reagent portfolio.

10Reagents for Hematology Analyzer
CategoryIn-vitro diagnostic reagent (hematology)
Description

Reagents for use with hematology analyzers, including compatible consumables for the CYB series five-diff hematology instruments.

11Reagents for Immune Analyzer (System Reagents)
CategoryIn-vitro diagnostic reagent (immunoassay)
Description

System reagents designed for use with immune analyzer instruments, part of the company's integrated reagent portfolio.

12COVID-19 2019-nCoV IgM/IgG Fluorescence Immunoassay Test Kit
CategoryIn-vitro diagnostic reagent (infectious disease / COVID-19)
Description

A fluorescence immunochromatographic test kit for the qualitative detection of SARS-CoV-2 (2019-nCoV) IgM and IgG antibodies in blood samples, with clinical validation showing 97.1% IgM and 98.2% IgG positive rates.

13Reagents for Urine Analysis
CategoryIn-vitro diagnostic reagent (urine analysis)
Description

Urine sediment detection reagents (Class I medical devices) included in the company's IVD reagent product range.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

中山市创艺生化工程有限公司

In-Vitro Diagnostics (IVD)gd-cy.com

Zhongshan Chuangyi Biochemical Engineering Co., Ltd. (CYBIO) is a privately held Chinese IVD manufacturer producing five-part differential hematology analyzers, POCT fluorescence immunoassay instruments, and biochemical/immune/urine reagents for hospital clinical laboratories and point-of-care settings, distributed through 300+ China dealers and export channels across emerging markets.

What 中山市创艺生化工程有限公司 does

Zhongshan Chuangyi Biochemical Engineering Co., Ltd. (中山市创艺生化工程有限公司 / CYBIO) is a privately held Chinese in-vitro diagnostics (IVD) manufacturer founded in 1999 and headquartered in Zhongshan, Guangdong Province, with a satellite R&D center in Shenzhen established in 2014. The company designs, manufactures, and sells diagnostic instruments and the corresponding consumable reagents for clinical laboratories and point-of-care settings. Its instrument portfolio spans the CYB-series of five-part differential hematology analyzers (CYB-5200, CYB-5500, CYB-6000, CYB-6800), the CYFIA-series and AFS-4000 dry immunofluorescence POCT analyzers, and an integrated all-in-one platform combining bidirectional-LIS hematology analysis with fluorescence immunoassay. The reagent portfolio covers hematology reagents, biochemistry reagents, immune-assay system reagents, urine sediment detection reagents, and a COVID-19 2019-nCoV IgM/IgG fluorescence immunochromatographic test kit. The company's core technical differentiator is an industry-first ultrasonic anti-clog method that clears counting apertures in 3–15 minutes, reducing downtime versus conventional systems.

The business operates a hybrid go-to-market model: direct sales support for key hospital and clinical-lab accounts, complemented by a national distributor network of 300+ dealers reaching 1,000+ terminal customers across China, plus international export channels covering the Middle East, West Asia, Africa, Latin America, and Eastern Europe (including Romania and Poland). Revenue is generated through hardware sales of instruments paired with recurring reagent consumables, which is the standard IVD razor-and-blade model. The company holds ISO 9001, ISO 13485, EU CE, and US FDA certifications, and is designated a National High-tech Enterprise with a 2019 Guangdong R&D innovation rating of A3 (top 2% province-wide). Manufacturing is conducted at a 15 mu (≈2.5-acre) factory in Zhongshan's National Health Industry Base, with a workforce of approximately 200 employees including 70 R&D staff, an in-house doctor workstation, and a provincial/municipal engineering technology research center.

The company has pursued an IPO initiative since 2016 and has historically expanded through internal R&D and product launches rather than M&A. Leadership is concentrated in founder He Linhui (何林辉), who serves as General Manager and has driven the firm's 21-year IVD focus. The most recent strategic pivot was a 2020 product portfolio expansion to include a COVID-19 rapid serology kit and emergency disinfectant production in response to the pandemic, alongside formal performance-management reforms and a planned hematology reagent production line renovation.

中山市创艺生化工程有限公司 firmographics

Firmographics
Name
中山市创艺生化工程有限公司
Legal name
中山市创艺生化工程有限公司
Website
https://gd-cy.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
1–10 employees
Short description
Zhongshan Chuangyi Biochemical Engineering Co., Ltd. (CYBIO) is a privately held Chinese IVD manufacturer producing five-part differential hematology analyzers, POCT fluorescence immunoassay instruments, and biochemical/immune/urine reagents for hospital clinical laboratories and point-of-care settings, distributed through 300+ China dealers and export channels across emerging markets.
Ownership category
akta.pro rank

Where 中山市创艺生化工程有限公司 is headquartered

Location

Headquarters

HQ city
Zhongshan
HQ country
China
HQ region
Asia

Offices2 records

Markets served

中山市创艺生化工程有限公司 business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Hematology Analyzers and Reagents: Sale of 5-part differential hematology analyzers (CYB series) and compatible blood cell analysis reagents. Instruments sold alongside consumable reagent packages, creating recurring revenue from reagent restocking.
  2. Biochemical Reagents: Biochemical analyzer reagents for clinical chemistry testing, sold as consumable reagents.
  3. Immune Analyzer Reagents: System reagents and fluorescence immunochromatography reagent kits for immune analyzers, including COVID-19 IgM/IgG detection kit.
  4. Urine Analysis Reagents: Urinary sediment detection reagents for urine analysis testing.
  5. POCT Instruments and Reagents: Point-of-care testing instruments (CYFIA series, AFS-4000) and associated dry fluorescence immunoassay reagent kits for rapid bedside diagnostics.
  6. Disinfectant Products: During the COVID-19 pandemic, the company pivoted to produce disinfectant products (84消毒液, 复方季铵盐消毒剂, 聚维酮碘消毒剂) to support epidemic control, donated valued at 300,000 yuan.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

中山市创艺生化工程有限公司 product offering

Product offering

Core offering

Zhongshan Chuangyi Biochemical Engineering Co., Ltd. (CYBIO) is an in-vitro diagnostics (IVD) manufacturer that designs, produces, and sells clinical laboratory instruments and reagents. The product portfolio includes five-part differential hematology analyzers (CYB-5200, CYB-5500, CYB-6000, CYB-6800), dry fluorescence immunofluorescence POCT analyzers (CYFIA-2000, CYFIA-3000, AFS-4000), an integrated bidirectional LIS hematology-immunoassay all-in-one platform, and a full reagent line covering hematology, biochemistry, immunoassay, urine analysis, and COVID-19 IgM/IgG detection.

Product overview

Zhongshan Chuangyi Biochemical Engineering Co., Ltd (中山市创艺生化工程有限公司 / CYBIO) is a professional in-vitro diagnostics (IVD) manufacturer offering a dual-track product portfolio: (1) diagnostic instruments — the CYB-series five-part differential hematology analyzers (CYB-5200, CYB-5500, CYB-6000, CYB-6800) featuring proprietary ultrasonic anti-clog technology; the CYFIA-series and AFS-4000 dry immunofluorescence POCT analyzers; and the integrated All-in-One platform combining bidirectional LIS hematology and fluorescence immunoassay in a single system; (2) IVD reagents — covering biochemistry analyzer reagents, hematology analyzer reagents, immune analyzer system reagents, urine sediment detection reagents, and the COVID-19 2019-nCoV IgM/IgG fluorescence immunochromatographic test kit. The company operates two R&D centers (Zhongshan and Shenzhen) and maintains nationwide sales coverage in China plus international distribution in the Middle East, Africa, Latin America, and Europe.

Differentiator

Problem solved

Functional benefit

Products and services

  • CYB-5200 Five-Diff Hematology Analyzer A five-part differential hematology analyzer for automated blood cell counting and classification in clinical laboratory settings.
  • CYB-5500 Five-Diff Hematology Analyzer A five-part differential hematology analyzer representing the company's flagship hematology instrument line for clinical blood cell analysis.
  • CYB-6000 Five-Diff Hematology Analyzer A five-part differential hematology analyzer in the CYB series, designed for automated hematology testing in clinical settings.
  • CYB-6800 Five-Diff Hematology Analyzer A five-part differential hematology analyzer featuring proprietary ultrasonic anti-clog technology that clears counting apertures in 3-15 minutes, with bidirectional LIS connectivity.
  • CYFIA-2000 Dry Immunofluorescence Analyzer A dry fluorescence immunofluorescence analyzer for point-of-care testing, designed for rapid bedside or clinic-side diagnostic results.
  • CYFIA-3000 Dry Immunofluorescence Analyzer A dry fluorescence immunofluorescence analyzer for POCT use, supporting single-channel testing workflows in clinical and point-of-care environments.
  • AFS-4000 Full-Automatic Dry Immunofluorescence Analyzer A fully automatic dry fluorescence immunofluorescence analyzer designed for high-throughput clinical diagnostic testing at point of care.
  • Two-Way LIS Hematology Analyzer – Fluorescence Immunoanalyzer All-in-One Instrument An integrated analysis platform combining five-diff hematology analysis with fluorescence immunoassay capabilities, featuring bidirectional LIS connectivity for seamless laboratory data management.
  • Reagents for Chemistry (Biochemical) Analyzer Biochemical assay reagents compatible with chemistry analyzers, forming part of the company's IVD reagent portfolio.
  • Reagents for Hematology Analyzer Reagents for use with hematology analyzers, including compatible consumables for the CYB series five-diff hematology instruments.
  • Reagents for Immune Analyzer (System Reagents) System reagents designed for use with immune analyzer instruments, part of the company's integrated reagent portfolio.
  • COVID-19 2019-nCoV IgM/IgG Fluorescence Immunoassay Test Kit A fluorescence immunochromatographic test kit for the qualitative detection of SARS-CoV-2 (2019-nCoV) IgM and IgG antibodies in blood samples, with clinical validation showing 97.1% IgM and 98.2% IgG positive rates.
  • Reagents for Urine Analysis Urine sediment detection reagents (Class I medical devices) included in the company's IVD reagent product range.

Quantifiable outcome

  • R&D innovation capability rated A3 (top 2% in Guangdong province, top 8 in Zhongshan city)
  • +2 more outcomes

Companies that use 中山市创艺生化工程有限公司

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles3 records

中山市创艺生化工程有限公司 technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

中山市创艺生化工程有限公司 partnerships and signals

Strategic signal

Scale indicators10 records

Recent moves9 records

Expansion highlights4 records

中山市创艺生化工程有限公司 competitors and assessment

Company assessment

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

中山市创艺生化工程有限公司 compliance and trust

Trust signal

Compliance4 records

中山市创艺生化工程有限公司 financial estimates

Financial estimate

Revenue estimate

Valuation estimate

中山市创艺生化工程有限公司 leadership team

Management profile

Number of profiles

Profiles7 records

中山市创艺生化工程有限公司 funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

中山市创艺生化工程有限公司 M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 中山市创艺生化工程有限公司

What does 中山市创艺生化工程有限公司 do?

Zhongshan Chuangyi Biochemical Engineering Co., Ltd. (CYBIO) is an in-vitro diagnostics (IVD) manufacturer that designs, produces, and sells clinical laboratory instruments and reagents. The product portfolio includes five-part differential hematology analyzers (CYB-5200, CYB-5500, CYB-6000, CYB-6800), dry fluorescence immunofluorescence POCT analyzers (CYFIA-2000, CYFIA-3000, AFS-4000), an integrated bidirectional LIS hematology-immunoassay all-in-one platform, and a full reagent line covering hematology, biochemistry, immunoassay, urine analysis, and COVID-19 IgM/IgG detection.

Is 中山市创艺生化工程有限公司 a public or private company?

中山市创艺生化工程有限公司 is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was 中山市创艺生化工程有限公司 founded?

中山市创艺生化工程有限公司 was founded in 1999. It employs 1 to 10 people.

Where is 中山市创艺生化工程有限公司 based?

中山市创艺生化工程有限公司 is headquartered in Zhongshan, China, in the Asia region.

How does 中山市创艺生化工程有限公司 make money?

Six revenue lines are on record. Hematology Analyzers and Reagents are the primary driver. The others are biochemical Reagents, immune Analyzer Reagents, urine Analysis Reagents, POCT Instruments and Reagents and disinfectant Products.

Does 中山市创艺生化工程有限公司 have an API?

No public API is recorded for 中山市创艺生化工程有限公司.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales